survival
414 results
1 - 100
survival
survival analysis
survival bias
disease-free survival
progression-free survival
time, restricted mean survival
curve
sex
chain
risdiplam
tebentafusp
trametinib
tucatinib
lutetium lu-177 vipivotide tetraxetan
encorafenib
durvalumab
acalabrutinib
avelumab
PFS
cabozantinib
olaratumab
glasdegib
vilobelimab
abatacept
osimertinib
defibrotide
gilteritinib
ensartinib
margetuximab
ripretinib
trabectedin
mogamulizumab
ipilimumab
daunorubicin/cytarabine liposomal
dacomitinib
lazertinib
time-to-event analysis
eriBULin
isatuximab
fruquintinib
tremelimumab
datopotamab deruxtecan
nusinersen
daratumumab
elotuzumab
necitumumab
abemaciclib
ribociclib
fosdenopterin
riluzole
alectinib
lonafarnib
cholic acid
palbociclib
capivasertib
amivantamab
peginterferon alfa-2B
drowning
vandetanib
omacetaxine
binimetinib
lutetium lu 177 dotatate
selective advantage
belatacept
sebelipase alfa
nivolumab
niraparib
midostaurin
tivozanib
eplerenone
fastidious
clinical benefit
erlotinib
olaparib
lenvatinib
lisinopril
hydralazine/isosorbide dinitrate
bias
alglucosidase
PONATinib
cemiplimab
gefitinib
resuscitation
denosumab




